Temporal trends in the treatment of pediatric type I diabetes and impact on acute outcomes

被引:75
作者
Svoren, Britta M.
Volkening, Lisa K.
Butler, Deborah A.
Moreland, Elaine C.
Anderson, Barbara J.
Laffel, Lori M. B.
机构
[1] Joslin Diabet Ctr, Pediat & Adolescent Sect, Boston, MA 02215 USA
[2] Joslin Diabet Ctr, Genet & Epidemiol Sect, Boston, MA 02215 USA
[3] Joslin Diabet Ctr, Behav & Mental Hlth Sect, Boston, MA 02215 USA
[4] Harvard Univ, Sch Med, Childrens Hosp Boston, Dept Med,Div Endocrinol, Boston, MA 02115 USA
[5] Univ Alabama Birmingham, Childrens Hosp, Div Pediat Endocrinol, Birmingham, AL USA
[6] Baylor Coll Med, Houston, TX 77030 USA
关键词
D O I
10.1016/j.jpeds.2006.12.009
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objective To evaluate temporal trends in pediatric type 1 diabetes (T1DM) management and resultant effects on outcomes. Study design Two pediatric T1DM cohorts were followed prospectively for 2 years and compared; Cohort 1 (N = 299) was enrolled in 1997 and Cohort 2 (N = 152) was enrolled in 2002. In both cohorts, eligible participants were identified and sequentially approached at regularly scheduled clinic visits until the target number of participants was reached. Main outcome measures were hemoglobin A1c (A1c), body mass index Z score and incidence rate (IR; per 100 patient-years) of hypoglycemia, hospitalizations, and emergency room (ER) visits. Results At baseline, Cohort 2 monitored blood glucose more frequently than Cohort 1 (>= 4 times/day: 72% vs 39%, P < .001) and was prescribed more intensive therapy than Cohort 4 (>= 3 injections/day or pump: 85% vs 65%, P <.001). A1c was lower in Cohort 2 than Cohort 1 at baseline (8.4% vs 8.7%, P = .03) and study's end (8.7% vs 9.0%, P = .04). The cohorts did not differ in Z-BMI (0.83 vs 0.79, P = .57) or IR of hospitalizations (11.2 vs 12.9, P = .38). Cohort 2 had lower IR of total severe hypoglycemic events (29.4 vs 55.4, P < .001) and ER visits (22.0 vs 29.3, P = .02). Conclusions T1DM management intensified during 5 years between cohorts and was accompanied by improved A1c and stable Z-BMI. Along with improved control, IR of severe hypoglycemia and ER visits decreased by almost 50% and 25%. respectively.
引用
收藏
页码:279 / 285
页数:7
相关论文
共 45 条
[1]  
Am Diabetes Assoc, 2006, DIABETES CARE, V29, pS4
[2]   IMPAIRED INSULIN ACTION IN PUBERTY - A CONTRIBUTING FACTOR TO POOR GLYCEMIC CONTROL IN ADOLESCENTS WITH DIABETES [J].
AMIEL, SA ;
SHERWIN, RS ;
SIMONSON, DC ;
LAURITANO, AA ;
TAMBORLANE, WV .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (04) :215-219
[3]   Meta-analysis of the effect of insulin lispro on severe hypoglycemia in patients with type 1 diabetes [J].
Brunelle, RL ;
Llewelyn, J ;
Anderson, JH ;
Gale, EAM ;
Koivisto, VA .
DIABETES CARE, 1998, 21 (10) :1726-1731
[4]   Self-monitoring of blood glucose in children and teens with diabetes [J].
Bui, H ;
Perlman, K ;
Daneman, D .
PEDIATRIC DIABETES, 2005, 6 (01) :50-62
[5]   The impact of a decade of changing of severe hypoglycemia in a population-based cohort of children with type 1 diabetes [J].
Bulsara, MK ;
Davis, EA ;
Holman, CD ;
Jones, TW .
DIABETES CARE, 2004, 27 (10) :2293-2298
[6]   The impact of the Diabetes Control and Complications Trial and Humalog insulin or glycohemoglobin levels and severe hypoglycemia in type 1 diabetes [J].
Chase, HP ;
Lockspeiser, T ;
Peery, B ;
Shepherd, M ;
MacKenzie, T ;
Anderson, J ;
Garg, SK .
DIABETES CARE, 2001, 24 (03) :430-434
[7]   Recent trends in hospitalization for diabetic ketoacidosis in Ontario children [J].
Curtis, JR ;
To, T ;
Muirhead, S ;
Cummings, E ;
Daneman, D .
DIABETES CARE, 2002, 25 (09) :1591-1596
[8]   FACTORS AFFECTING GLYCOSYLATED HEMOGLOBIN VALUES IN CHILDREN WITH INSULIN-DEPENDENT DIABETES [J].
DANEMAN, D ;
WOLFSON, DH ;
BECKER, DJ ;
DRASH, AL .
JOURNAL OF PEDIATRICS, 1981, 99 (06) :847-853
[9]   Persistent differences among centers over 3 years in glycemic control and hypoglycemia in a study of 3,805 children and adolescents with type 1 diabetes from the Hvidore Study Group [J].
Danne, T ;
Mortensen, HB ;
Hougaard, P ;
Lynggaard, H ;
Aanstoot, HJ ;
Chiarelli, F ;
Daneman, D ;
Dorchy, H ;
Garandeau, P ;
Greene, SA ;
Hoey, H ;
Holl, RW ;
Kaprio, EA ;
Kocova, M ;
Martul, P ;
Matsuura, N ;
Robertson, KJ ;
Schoenle, EJ ;
Sovik, O ;
Swift, PGF ;
Tsou, RM ;
Vanelli, M ;
Åman, J .
DIABETES CARE, 2001, 24 (08) :1342-1347
[10]   Clinical outcomes with insulin lispro compared with human regular insulin: A meta-analysis [J].
Davey, P ;
Grainger, D ;
MacMillan, J ;
Rajan, N ;
Aristides, M ;
Gliksman, M .
CLINICAL THERAPEUTICS, 1997, 19 (04) :656-674